Protandim® Product Line was Lifevantage’s largest product and service line in fiscal 2026, bringing in $81.99M of $182.59M (45%).
| Product and Service | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | FY 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Protandim® Product Line | $119.72M | $104.14M | $95.33M | $81.99M | ||||||
| Truescience® Product Line | $49.49M | $56.25M | $48.71M | $37.85M | ||||||
| Lifevantage® Product Line | — | $15.68M | $61.33M | $32.26M | ||||||
| Other | $44.18M | $4.50M | $5.73M | $4.40M | ||||||
| Product & Service, Other | — | — | — | — | ||||||
| Axio® Product Line | — | $13.38M | $15.31M | $15.01M | ||||||
| Lovebiome Product Line | — | — | — | $9.12M | ||||||
| Physiq™ Product Line | — | $3.83M | — | — | ||||||
| Petandim® Product Line | — | $2.40M | $2.12M | $1.96M | ||||||
| Total | $213.40M | $200.16M | $228.53M | $182.59M |
Lifevantage brought in $182.59M from its seven product and service lines in fiscal 2026, the year ended June 30, 2026. Lifevantage regrouped these lines after fiscal 2025, so the total does not compare directly with that year's $228.53M. Protandim® Product Line was the largest at $81.99M (44.9%), ahead of Truescience® Product Line at $37.85M (20.7%) and Lifevantage® Product Line at $32.26M (17.7%). The other four lines brought in $30.49M combined.
Compared with fiscal 2025, every line above 2% of revenue shrank. Axio® Product Line held up best, down 2.0% to $15.01M, and Lifevantage® Product Line fell the most, down 47.4% to $32.26M.
Lifevantage began breaking out Lifevantage® Product Line in fiscal 2024, Axio® Product Line in fiscal 2024, Lovebiome Product Line in fiscal 2026 and Petandim® Product Line in fiscal 2024. Lifevantage stopped reporting Physiq™ Product Line as a separate line after fiscal 2024, when it brought in $3.83M.
United States was Lifevantage’s largest region in fiscal 2026, bringing in $135.40M of $182.59M (74%).
| Geography | FY 2011 | FY 2012 | FY 2013 | FY 2014 | FY 2015 | FY 2016 | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | FY 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Americas | $155.36M | — | — | — | ||||||||||||
| United States | — | $145.68M | $178.44M | $135.40M | ||||||||||||
| Asia/Pacific Europe | $58.04M | — | — | — | ||||||||||||
| Asia/Pacific &Amp; Europe | — | — | — | — | ||||||||||||
| Asia & Pacific | — | — | — | — | ||||||||||||
| Other Foreign Markets | — | $27.50M | $24.69M | $23.03M | ||||||||||||
| Japan | — | $26.99M | $25.39M | $24.15M | ||||||||||||
| Total | $213.40M | $200.16M | $228.53M | $182.59M |
Lifevantage brought in $182.59M from its three regions in fiscal 2026, the year ended June 30, 2026. That was down 20.1% from $228.53M in fiscal 2025. United States was the largest at $135.40M (74.2%), ahead of Japan at $24.15M (13.2%) and Other Foreign Markets at $23.03M (12.6%).
Compared with fiscal 2025, every region above 2% of revenue shrank. Japan held up best, down 4.9% to $24.15M, and United States fell the most, down 24.1% to $135.40M.
Lifevantage began breaking out United States in fiscal 2024 and Other Foreign Markets in fiscal 2024. Lifevantage stopped reporting Americas ($155.36M in fiscal 2023) and Asia/Pacific Europe ($58.04M in fiscal 2023) as separate regions.
Lifevantage (LFVN) reports its revenue by product and service and by geography. In fiscal 2026, Protandim® Product Line was its largest product and service line, bringing in $81.99M (44.9% of the total), followed by Truescience® Product Line at $37.85M (20.7%).
Protandim® Product Line was Lifevantage's largest product and service line in fiscal 2026, bringing in $81.99M, or 44.9% of the $182.59M total across its seven product and service lines.
United States was Lifevantage's largest region in fiscal 2026, bringing in $135.40M, or 74.2% of the $182.59M total across its three regions.
Every figure comes from Lifevantage's annual financial filings, as reported. Each line keeps the name Lifevantage gives it, and years follow its fiscal calendar.
Lifevantage's revenue by product and service goes back to fiscal 2017, with figures through fiscal 2026. The latest four fiscal years are free to view, and the full history is available with a Business Quant subscription.